Pancreatic Cancer section

Prostate Cancer News & Features

Radiotherapy Plus Hormone Therapy Improves Long-term Survival for Patients With Prostate Cancer

Radiotherapy in combination with anti-androgen hormone therapy halves the risk of death from prostate cancer 15 years after diagnosis compared with hormone therapy alone.

Hsp90 Inhibition Overcomes Hormone Resistance in Some Aggressive Prostate Cancers

The second-generation hsp90 inhibitor onalespib may be beneficial for men with prostate cancer that no longer responds to androgen deprivation therapy

Diet Can Affect Aggressiveness of Prostate Cancer

Diet Can Affect Aggressiveness of Prostate Cancer

Research also suggests that statins may help counteract harmful effect of fatty foods

Physical Activity May Improve Prostate Cancer Prognosis

Physical Activity May Improve Prostate Cancer Prognosis

A moderate to high level of physical activity before and after diagnosis may improve prognosis in patients with non-metastatic prostate cancer.

Shortened Radiation Therapy Schedule No Worse Than Conventional Radiotherapy in Low-Risk Prostate Cancer

Shortened Radiation Therapy Schedule No Worse Than Conventional Radiotherapy in Low-Risk Prostate Cancer

Treatment with a hypofractionated radiotherapy (HRT) schedule achieved similar efficacy as treatment with the longer, conventional RT (CRT) schedule in men with low-risk prostate cancer.

Prostate Cancer Videos

Prostate Cancer Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs